Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07038317

A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status

Identifying and Examining the Effects of Source and Presentation on Responses to Electronic Cigarette Public Education Messages in Young Adult Vapers and Non-vapers

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
University of Hawaii · Academic / Other
Sex
All
Age
18 Years – 24 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to examine if e-cigarette education messages delivered using a source and presentation tailored to one's vaping status influences young adults' vaping behaviors. The main questions it aims to answer are: 1. Does receiving e-cigarette education messages presented using a source (expert or peer) and sidedness (one or two-sided) optimized for the current vaper group influence vaping cessation among young adults who vape daily? 2. Does receiving e-cigarette education messages presented using a source (expert or peer) and sidedness (one or two-sided) optimized for the non-vaper group influence vaping initiation among young adults who are susceptible to vaping? Participants will be randomly assigned to either the treatment (receiving messages tailored to one's vaping status) or the control (receiving non-tobacco messages) condition and receive SMS three times per week over the course of 6 months. They will complete self-report assessment and show salivary cotinine results for nicotine testing at 4 timepoints.

Conditions

Interventions

TypeNameDescription
OTHERInterventionIntervention involves e-cigarette education messages tailored to participants' vaping status that will be sent out in SMS via text messaging three times per week over the course of 6 months.
OTHERControlParticipants will receive non-tobacco messages (messages about sun safety) three times per week over the course of 6 months.

Timeline

Start date
2026-04-30
Primary completion
2027-12-30
Completion
2028-01-31
First posted
2025-06-26
Last updated
2026-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07038317. Inclusion in this directory is not an endorsement.